Cell Culture Market at a CAGR of 6.4% from 2021 to 2030

Cell Culture Market Outlook 2028

The global cell culture market was valued at US$ 16.6 Bn in 2020

It is estimated to expand at a CAGR of 6.4% from 2021 to 2028

The global cell culture market is expected to reach the value of US$ 30 Bn by the end of 2030

Get the sample copy of report@ https://qyresearchmedical.com/sample/111778

Analysts’ Viewpoint on Cell Culture Market Scenario

The rising prevalence of cancer and cardiovascular diseases is driving the global cell culture market. Biological products produced from the cell culture are used for the treatment of these diseases. Technological advancement in pharmaceutical industry creating potential revenue opportunities for the market players operating in the cell culture market. The increasing investment in R&D in cell culture to explore innovative solutions for the treatment of various illnesses in the body is accelerating market growth. Market players are exploring new approaches to culturing or utilizing cells for various applications. Rapid expansion of pharmaceutical companies, growth and advancement in drug development & discovery, rapidly expanding clinical research institutes in developed regions are fueling the growth of the cell culture market. High costs and unavailability of suitable infrastructure for research activities are the factors affecting the growth of the global cell culture market.

Rise in Demand for Biopharmaceuticals Promotes Market Growth

Due to the increasing demand for biosimilar and biologics products for the treatment of cancer and various other chronic and cardiovascular diseases, cell culture method is found to be effective, efficient in the biopharmaceutical sector. Cell culture products increase productivity by lowering manufacturing costs. Cell culture is a process of removing cells from an animal or plant source, and use these cells for creating biosimilar or biologic therapeutics. These cells can be kept and grow in a controlled environment such as ideal temperature, gases, pH, and humidity. These factors are essential for the growth and proliferation of the cells. Cell removal can be carried out either by mechanical or enzymatic method before cultivation. The cells to be grown can also be derived from a cell line or cell strain that has already been established. Biosimilar products has gained tremendous popularity in North America and Europe. This factor contributes to the global cell culture market growth.

Challenges Associated with Fetal Bovine Serum (FBS) in Cell Culture Market

Market players are targeting the rising production of fetal bovine serum (FBS) by innovative strategies. Fetal bovine serum (FBS) is made from the bovine fetuses that are removed from pregnant cows during slaughter. Animal cell culture mediums contain fetal bovine serum (FBS). It is generally obtained with a cardiac puncture without the need of anesthetic. Increase in awareness of animal welfare activities is the factor affecting the growth of the cell culture market. There is a huge reduction in the fetal bovine serum production across the globe. This factor is likely to affect the market growth in the upcoming years.

Profitable Revenue Opportunities for North America Market Players

North America is expected to account for the major share in the global cell culture market during the forecast period. The lucrative presence of market players operating in the North America cell culture market is the major factor responsible for the market growth in the region. The North America cell culture market is also driven by the strong support from government, increasing investment in cell-based research & development, regulatory approvals for cell culture-based vaccines, rapidly rising prevalence of diseases such as cancer, etc. Market players working in the cell culture market in North America are expected to witness potential growth opportunities in the market. In addition, technological advancement in healthcare, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies are also fueling the growth of the market in the region. Countries in the Asia Pacific market such as China and India are the fastest growing region in the cell culture market. Rapid urbanization and increasing investment in research activities are the key factors contributing to the market growth in Asia Pacific.

Impact of COVID-19 and Increase in Product Development

The rapidly spreading coronavirus across the globe has created opportunities for manufacturers operating in the global cell culture market due to rising need of vaccines, which demand research-based activities, along with clinical trial of vaccines. The global cell culture market is booming due to the surging demand for biopharmaceuticals, increase in product development by key market contributors, and development of novel vaccines. There is an increasing demand for cost-effective, reliable, low-risk, and highly efficient cell culture products such as bioreactors, media, reagents, and sera for the creation of high-yield cell lines. In order to fulfill this demand, many cell culture manufacturers are focusing on increasing production of innovative products.

Cell Culture Market: Overview

The global cell culture market for the historical period 2017–2019 and forecast period 2021–2028, rise in demand for biopharmaceuticals, increase in product development by players, and rapid development of novel vaccines are projected to drive the global cell culture market during the forecast period

Increase in Product Development by Manufacturers: Key Driver

Demand for cost-effective and highly efficient cell culture items such as bioreactors, media, reagents, and sera for the creation of high-yield cell lines has increased, resulting in an increase in the number of new product launches. This factor is expected to fuel the growth of the global cell culture market during the forecast period.

Major manufacturers are continuously attempting to diversify their product line by introducing new and innovative systems for cost-effective, low-risk large-scale production. Merck, for instance, introduced capsule filters in 2018 to help reduce the possibility of contamination in bioreactors. Mycoplasma and bacteria are separated from cell culture media using these filters.

Rise in Demand for Biopharmaceuticals to Boost Market Growth

One of the most significant phases in the creation of biosimilar/biologic therapeutics is cell culture, which helps to boost efficiency and productivity while lowering manufacturing costs

Increase in demand for biosimilars and other biologics for the treatment of chronic diseases such as cancer and diabetes globally has resulted in rise in demand for efficient and cost-effective products. This is expected to drive the global cell culture market during the forecast period.

Infliximab, the first biosimilar monoclonal antibody, was approved for autoimmune diseases, which includes Crohn’s disease, ulcerative colitis, and rheumatoid arthritis, and quickly gained market share in key countries in Europe. In Europe, there are now three competing infliximab biosimilar brands: MundiPharma’s Remsima, Pfizer/Inflectra, Hospira’s and Biogen’s Flixabi.

With approximately 240 biosimilars in development (counting only those that have been publicly revealed), launches will become more frequent. This is likely to drive the global cell culture market over the next few years.

Ethical Issues Associated with Use of Fetal Bovine Serum to Hamper Market

Animal cell culture mediums frequently contain fetal bovine serum (FBS). It is made from bovine fetuses that are removed from pregnant cows during slaughter. FBS is generally obtained with a cardiac puncture without the need of anesthetic. The current technique of fetal blood collecting is inhumane since fetuses are likely to be in pain and/or discomfort.

Due to increased criticism from animal welfare organizations, production of fetal bovine serum is likely to decline in the next few years. This drop in FBS production is expected to act as a restraint of the global cell culture market during the forecast period.

Apart from moral difficulties, there are a number of scientific and technological issues with the use of FBS in cell culture, which are prompting users to choose for alternatives

Cell Culture Market: Competition Landscape

This report profiles major players in the global cell culture market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global cell culture market is consolidated with the presence of five major global players

Leading players operating in the global cell culture market are

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• GE Healthcare
• Lonza Group
• Sartorius AG
• Becton
• Dickinson and Company
• Corning, Inc.
• Eppendorf AG
• VWR International
• PromoCell GmbH, among others

Key Questions Answered in Cell Culture Market Report

• What is the scope of growth of product companies in the global cell culture market?
• What will be the Y-o-Y growth of the global cell culture market between 2017 and 2028?
• What is the influence of changing trends on the global cell culture market?
• Will North America be the most profitable market for cell culture providers?
• Which factors are anticipated to hamper the growth of the global cell culture market during the forecast period?
• Which are the leading companies in the global cell culture market?

Cell Culture Market – Segmentation

Product

• Instruments
• Media
• Sera
• Reagents

End-user

• Biotechnology Companies
• Pharmaceutical Companies
• Academic Institutes
• Research Institutes

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111778/2900